Your search returned 20 results.

Results
	1.	Patient and healthcare provider perceptions of acceptability of fingerstick point-of-care hepatitis C testing at Aboriginal Community Controlled Health Services (ACCHS) in Australia by Lafferty L Beadman M Ward J Treloar C et al Series: International Journal of Drug PolicyLondon Elsevier 2024 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	2.	Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs : The ETHOS engage study by Valerio H; Marshall A D; Conway A; Treloar C; Carter L; Marinello M; Henderson C; Amin J; Read P; Silk D; Degenhardt L; Prian B; Alavi M; Dore G J; Grebely J Series: International Journal of Drug Policy ; Vol. 127London Elsevier 2024 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	3.	Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program ; the TEMPO Pilot Study by Grebely J Gillilver R McNaughton T et al Series: International Journal of Drug Policy ; Vol. 114London Elsevier 2023 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	4.	Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: a mixed methods study of syringe services program perspectives by Austin E J Corcorran M A Briggs E S et al Series: International Journal of Drug Policy ; Vol. 109London Elsevier 2022 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	5.	Peer to peer communication about hepatitis C treatment amongst people who inject drugs: a longitudinal qualitative study by Goutzamanis S Doyleac J S Horyniak D et al Series: International Journal of Drug Policy ; Vol 87London Elsevier 2021 Online resources: Link to detailed abstract Availability: Items available for loan: Library (1).
	6.	“That was quick, simple, and easy”: patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison by Lafferty L Cochrane A Sheehan Y Treloar C Grebely J Lloyd A Series: International Journal of Drug Policy ; Vol. 99London Elsevier 2021 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	7.	“It's time!”: A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C by Walker S Wallace J Latham N Et al Series: International Journal of Drug Policy ; Vol. 97London Elsevier 2021 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	8.	The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada by Godin A Kronfli N Cox J et al Series: International Journal of Drug PolicyLondon Elsevier 2020 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	9.	Integration of hepatitis C treatment at harm reduction centers in Georgia - findings from a patient satisfaction survey by Butsashvilia M Kamkamidzea G Kajaiaa M et al Series: International Journal of Drug Policy ; 84London Elsevier 2020 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	10.	Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting by Rance J Grebely J Dore G J et al Series: International Journal of Drug Policy ; Vol. 77London Elsevier 2020 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	11.	Life projects: the transformative potential of direct-acting antiviral treatment for hepatitis C among people who inject drugs by Williams B Nelons D Seaman A et al Series: International Journal of Drug Policy ; 72 London Elsevier 2019 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	12.	Striving towards the elimination of HCV infection among PWID by Grebely J Treloar C Bruneau J et al Series: International Journal of Drug Policy ; 72London Elsevier 2019 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	13.	Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project by Rojasab T Di Beoab V Delorme J Series: International Journal of Drug Policy ; 72London Elsevier 2019 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	14.	Point-of-care hepatitis C testing from needle and syringe programs: an Australian feasibility study by Williams B Howell J Doyle J et al Series: International Journal of Drug Policy ; 72London Elsevier 2019 Online resources: Overview at Burnet Institute Journal article abstract Availability: Items available for loan: Library (1)Call number: testing.
	15.	Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy by Grebely J Bruneau J Bruggeman P et al Series: International Journal of Drug Policy \| ; 47London Elsevier 2017 Online resources: Click here to access online Availability: Items available for loan: Library (1)Call number: 3.1.
	16.	'Beyond the willing & the waiting' - the role of peer-based approaches in hepatitis C diagnosis & treatment by Henderson C Madden A Kelsall J Series: International Journal of Drug Policy ; 50London Elsevier 2017 Online resources: Click here to access online Availability: Items available for loan: Library (1)Call number: 5.2.
	17.	Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade by Scott N Doyle J Wilson J et al Series: International Journal of Drug Policy \| ; 47London Elsevier 2017 Online resources: Click here to access online Availability: Items available for loan: Library (1)Call number: 0.4.1.
	18.	Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996-2015 by Graham S Maher L Wand H et al Series: International Journal of Drug Policy \| ; 47London Elsevier 2017 Online resources: Click here to access online Availability: Items available for loan: Library (1)Call number: 7.4.
	19.	Interventions to Prevent HIV and Hepatitis C in People Who Inject Drug by MacArthur G van Velzen E et al Series: International Journal of Drug PolicyLondon Elsevier 2014 Online resources: Click here to access online Availability: Items available for loan: Library (1)Call number: 2.4.
	20.	Does Informing People Who Inject Drugs of their Hep C Status Influence by Aspinall E Weir A et al Series: International Journal of Drug PolicyLondon Elsevier 2014 Online resources: Click here to access online Availability: Items available for loan: Library (1)Call number: 2.4.

Refine your search

Availability

Authors

Item types

Locations

Series

Topics

Your search returned 20 results.